Overview
Status
Active
Registry date
2019-08-26
Share capital
5,000.00 PLN
Registered address
ul. Na Zjeździe 11, 30-527 Kraków, Poland
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $4,613 |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 301 days for 2023).
- 202526/06/2026
- 202404/07/2025
- 202312/05/2025
- 202202/11/2023
- 202128/10/2022
- 202012/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 974.75kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 78.92kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 845.15kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 414.53kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Ivana Waller – Dyrektor Zarządu
Mirna Šenjug Novak – Dyrektor Zarządu
Manner of representation
Each member of the management board represents the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Optimapharm Društvo S Ograničenom Odgovornošču za Zastupanje i Usluge | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-09-28.
58 1240 4719 1978 0010 9287 0669
92 1240 4719 1111 0010 9287 0630
54 1600 0003 1742 7435 9000 0008
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| SkinlabP.S.A. | $1,797,229.06 | skinlab.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org |
FAQ
The main business activity of Optimapharm focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 26, 2019.
The headquarters is located at: ul. Na Zjeździe 11, 30-527 Kraków.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $1,000,583, representing a decrease of 4.1% compared to 2023.
Yes, the company recorded a net profit of $26,546 in 2024, meaning the company decreased its profit by 41.3%.
The largest operating cost category falls under employee remuneration. This category amounted to $751,519 in 2024, representing 80% of all operating expenses.
Last updated: 2026-10-07